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ABSTRACT 
Ring opening reactions of benzoxazinone (2) with nitrogen and oxygen nucleophiles gave the corresponding benzamides 
(3)&(4) and benzoates (5).Quinazolinone derivatives (6) and (7) were obtained upon treatment of (2) with hydrazine 
hydrate and/or hydroxylamine hydrochloride.Triazole derivatives (8a – b) were obtained when (2) was subjected to react 
with semicarbazide and/or thiosemicarbazide respectively. Reaction of (2) with sodium azide gave a mixture of tetrazole 
derivative (9) and benzoimidazolone derivative (10). The antimicrobial activity of  some synthesized compounds was 
examined against bacteria, fungi and yeast. Some of the tested compounds showed promising activities. 
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1. INTRODUCTION 
          The reported biological and pharmacological activities of benzoxazinone and quinazolinone derivatives, such as 
anticonvulsant [1-3], antihistaminic [4-5], antihypertensive [6-8], analgesic [9-10], anti-inflammatory [11], antimicrobial 
[12-15] and antifungal [16-17] have stimulated us to synthesize some new derivatives of these classes of compounds with 
the hope of obtaining new structures with enhanced potency or finding new applications. Also we aimed to incorporate a 
sterically  bulky group such as phenyl group in position–2 to detect its role in the nature and ease of reaction of these 
compounds. 
2.1 RESULTS AND DISCUSSION  
          In continuation of our efforts to develop the synthesis and reactivity of benzoxazinone derivatives toward some 
nitrogen and oxygen nucleophilic reagents [8,18-21], we reported herein, the synthesis of novel 2–phenyl–6– iodo–3,1– 
benzoxazin–4–one (2) via condensation of benzoyl chloride with 5– iodoanthranilic acid in prydine via the intermediacy of 
benzoic acid derivative (1)(scheme1). The structures of (1,2) have been confirmed by their analytical data as well as 
spectroscopic data (IR,
1
H–NMR and MS).Ring opening of (2) with primary amines, such as 4–
methoxyaniline,benzylamine,ethylamine,methylamine and sec.butylamine beside hydrazinolysis with hydrazine hydrate 
and phenyl hydrazine gave the corresponding benzamide derivatives (3a–g) respectively (scheme 2). The structures of 
(3a–g) have been confirmed by their analytical data as well as spectroscopic data(IR,
1
H–NMR and MS).With secondary 
amines, such as morpholine, piperidine and /or piperazine in 1,4–dioxane, benzoxazinone(2) yielded the expected 
products (4a – c) respectively (scheme 2).The structures of (4a–c) have been confirmed by their analytical data as well as 
spectroscopic data (IR,
1
H–NMR and MS)..However, when the reaction was carried out in ethanol and/or n– butanol the 
ester products (5a–b)(scheme 2)were obtained in fairly good yield, which means that morpholine, piperidine and/or 
piperazine act as a base favoring the formation of alkoxide ion which promotes ring opening of (2) to give the esters (5a–
b); this observation was supported by the reaction of (2) with ethanol and/or n –butanol in the presence of pyridine as a 
base to give the esters (5a–b)(scheme 2). The structures of (5a–b) have been confirmed by their analytical data as well 
as spectroscopic data (IR,
1
H–NMR and MS). 
            On the other hand, hydrazinolysis of (2) with hydrazine hydrate or reaction with hydroxylamine hydrochloride in 
butanol gave the corresponding quinazolinone derivatives (6a–b) respectively (scheme 2), whose structures were 
confirmed by elemental analysis as well as spectroscopic data (IR,
1
H–NMR and MS). 
              Furthermore, fusion of (2) with ammonium acetate (at ca. 170°c) gave the quinazolinone derivative (7)(scheme 
3), whose structure was established by elemental analysis as well as spectroscopic data (IR,
1
H–NMR and MS). 
        Moreover, refluxing of (2) with semicarbazide and/or thiosemicarbazide in pyridine yielded the triazole derivatives 
(8a–b) respectively (scheme 3).The structures of (8a–b) have been confirmed by their analytical data as well as 
spectroscopic data (IR,
1
H–NMR and MS). 
       Reaction of benzoxazinone(2) with sodium azide in acetic acid afforded a mixture of tetrazole derivative (9) and 
benzoimidazolone derivative (10)(scheme 3) according to the following pathway:- 
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The structures of (9& 10) were elucidated by elemental analysis as well as spectral data(IR,
1
H–NMR and MS). 
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3a) R = - C6H4 (4 – OCH3), 3b) R = - CH2Ph, 3c) R = - CH2CH3, 3d) R = - CH3, 3e) R = - CH (CH3) CH2 CH3, 3f) R = - NH2, 
3g) R = - NHPh, 4a) X = O, 4b) X = CH2, 4c) X = NH, 5a) R = - C2H5,  
5b) R = n – C4H9, 6a) R = - NH2, 6b) R = - OH. 
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8a) X = O, 8b) X = S. 
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2.2Antibacterial, Antifungal and Antiyeast Activation of the Synthesized Compounds 
        The antimicrobial activities of the synthesized compounds were determined in vitro using the holeplate and filter paper 
disc method (Rosen, 1989) which considered the most commonly used technique for determining sensitivity of 
chemotherapeutic agents. Compounds were dissolved in 10% acetone at different concentrations (125, 250, 500 μg/ml). 
Agar plates were inoculated uniformly from fresh broth culture of Gram -ve bacteria (Escherichia coli), Gram +ve bacteria 
(Staphylococcus aureus), fungi (Aspergillus flavus), and yeast (Candida albicans). The disks were Incubated at 28°C for 
24hr, and the formed inhibition zones were diffused into the agar from the disk (this refers to the organism was inhibited by 
material) and were measured in mm [22-23]. 
Bacterial media: Nutrient agar and broth (pH 7.0), Peptone (0.5g), Beef extract (0.3g), Agar (15.0g) and distilled water 
(1000.0ml). 
Fungal media: MgSO4 (0.5g); KCl (0.5g); Sucrose (30.0g); FeSO4 (0.01g); NaNO3 (3.0g); K2HPO4 (1.0g); Agar (15.0g) 
and distilled water (1000.0 ml). 
 
Table 1: Antimicrobial activity of some synthesized compounds. 
compoun
d 
Bacteria Fungi Yeast 
 Echerichi
a coli (G 
-
) 
Staphylococc
us aureus (G 
+
) 
Aspergillu
s flavus 
(Fungus) 
Candida 
albicans 
 A MIC A MIC A MIC A MIC 
1 26 125 34 250 0.0 125 0.0 125 
2 0.0 125 0.0 250 0.0 125 0.0 125 
3a 0.0 500 0.0 500 0.0 250 0.0 250 
3b 0.0 125 0.0 125 0.0 250 0.0 500 
3c 0.0 250 0.0 125 0.0 250 0.0 250 
3d 0.0 125 0.0 125 0.0 250 0.0 250 
3e 0.0 125 0.0 250 0.0 125 0.0 125 
3f 0.0 125 0.0 125 0.0 25 0.0 125 
4a 0.0 125 0.0 250 0.0 125 0.0 125 
4b 0.0 500 0.0 250 0.0 125 0.0 250 
5a 25 250 33 250 0.0 125 13 250 
5b 39 250 43 125 0.0 125 0.0 250 
6a 10 250 11 125 0.0 250 0.0 250 
7 9 250 9 500 0.0 250 0.0 500 
 
A = Antimicrobial activity of tested compounds 
MIC = Minimum inhibitory concentration 
 
Conclusion 
Based on the results of the inhibition zoon and  Minimum inhibitory concentration (MIC)(μg/ml) adata in table (1) revealed 
that  aminoquinazolinon(6a) and quinazolinone (7)  showed promising antimicrobial activity while benzamide derivative(1) 
and ester derivatives( 5a) &(5b) exhibited high antibacterial and antifungal activities. Compounds 2,(3a-f) and (4a-b)  
exhibited no antimicrobial activity. 
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3. Experimental 
Melting points were measured on an electro thermal melting point apparatus. Elemental analyses were carried out at the 
micro analytical unit, Cairo University, Giza, Egypt. The IR spectra were measured on a Unicam SP-1200 spectrometer 
using KBr Wafer technique. The 
1
H-NMR spectra were measured in DMSO-d6 on a Varian plus instrument (300 MHz). 
Mass spectra were recorded on a shimadzu GC-MS QP- 1000EX instrument operating at 70 ev. Antimicrobial activity was 
carried out at micro analytical center, Faculty of science, Cairo University, Cairo, Egypt. 
3.1  2–Benzamido–5 –iodobenzoic acid (1) 
To a solution of 5 – iodoanthranilic acid (0.01 mol) in anhydrous pyridine (50mL), benzoyl chloride (0.01 mol) was added 
dropwise at room temperature with stirring for 30 min; then the reaction mixture was heated on a water bath for 5hr. After 
cooling, the reaction mixture was poured on ice cold hydrochloric acid. The produced mass was filtered off, washed with 
water, dried and recrystallized from benzene to give (1). 
Colour: brown, M.P.: 272- 273 C̊, Yield: 60%, IR (KBr)(ν, cm
-1
):3115 (NH), 1700, 1658 (C = O), 
1
H – NMR (DMSO – d6): δ 
(ppm): 12.09 (s, 1H, OH), 8.53 (s, 1H, NH), 8.29 (s, 1H, ArH), 8.01 – 7.95 (m, 3H, ArH), 7.66 – 7.57 (m, 3H, ArH), 7.36 (s, 
1H, ArH). MS, m/z (%): 367 (M 
+
, 100), 245 (100), 236 (50), 105 (100), 78 (95). 
Anal.Calcd. For C14H10NO3I (367.14): C, 45.80, H, 2.74; N, 3.81. Found: C, 46.01, H, 2.77; N,4.02. 
3.2  6–Iodo– 2–phenyl–(4H)–3, 1–benzoxazi –4 –one (2) 
A mixture of (1) (0.01 mol) and acetic anhydride (50 mL) was heated on a water bath for 5hr., the solid formed after 
removal of excess acetic anhydride was triturated with petroleum ether 40 – 60 ̊C and recrystallized from cyclohexane to 
give (2). 
Colour: white, M.P.: 173 – 174 ̊ C, Yield: 80%, IR (KBr) (ν, cm
-1
): 1755 (C=O), 1607 (C=N), 
1
H – NMR (DMSO – d6): δ 
(ppm): 8.39 (s, 1H, ArH), 8.26 – 8.17 (m, 3H, ArH), 7.68 – 7.48 (m, 4H, ArH). MS, m/z (%): 349 (M 
+
, 75), 305 (20), 105 
(100), 77 (100), 51 (35).Anal.Calcd. for C14H8NO2I (349.12): C, 48.16, H,2.31; N, 4.01. Found: C, 48.36, H, 2.40; N, 4.44. 
3.3  General method for synthesis (3a – g):- 
A mixture of (2) (0.01 mol) and primary amines, namely 4 – methoxy aniline, benzyl amine, ethyl amine, methyl amine, sec 
– butyl amine, hydrazine hydrate and phenyl hydrazine (0.01 mol), in ethanol (30 mL) was refluxed for 3hr. The solid 
separated after concentration of ethanol was filtered off, and recrystallized from a suitable solvent to give (3a – g). 
3.3.1   N–(4–Methoxy phenyl)– 2 –benzamido– 5– iodobenzamide (3a) 
Colour: white, M.P.: 180 – 182 ̊C, Yield: 70%,Recrystalized from: cyclohexane, IR (KBr) (ν, cm
-1
):3267, 3136 (NH), 1681, 
1648 (C=O).
1
H–NMR (DMSO – d6):δ (ppm): 11.80 (s, 1H, NH), 10.49 (s, 1H, NH), 8.45 - 8.23 (m, 3H, ArH), 7.95 – 7.88 
(m, 3H, ArH), 7.62 - 7.53 (m, 3H, ArH), 7.37- 6.82 (m, 3H, ArH), 3.70 (s, 3H, OCH3). MS, m/z (%): 472 (M 
+
, 3), 349 (12), 
271 (2), 123 (100), 105 (48), 77 (39). Anal.Calcd.For C21H17N2O3I (472.27): C, 53.41, H, 3.63; N, 5.93. Found: C, 53.48, H, 
3.67; N, 6.01. 
3.3.2   N– Benzyl –2–benzamido– 5– iodobenzamide (3b) 
Colour: white, M.P.: 184 – 185 C̊, Yield: 60%, Recrystallized from: ethanol, IR (KBr) (ν, cm
-1
):3296 (NH), 1680, 
1623(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 12.41 (s, 1H, NH), 9.48 (br, 1H, NH), 8.48 - 8.45 (d, 2H, ArH), 8.23 (s, 1H, 
ArH), 7.93- 7.88 (m, 3H, ArH), 7.63 - 7.54 (m, 3H, ArH), 7.37 – 7.24 (m, 4H, ArH), 4.53 – 4.51 (d, 2H, CH2). MS, m/z (%): 
456 (M +, 9), 447(14), 418 (16), 386 (14), 205 (15), 117 (18), 55 (100). Anal.Calcd.For C21H17N2O2I (456.27): C, 55.28, H, 
3.75; N, 6.14. Found: C, 54.99, H, 3.79; N, 6.20. 
3.3.3  N–Ethyl–2– benzamido– 5 –iodobenzamide (3c) 
Colour: white, M.P.: 109 – 111 ̊ C, Yield: 80%, Recrystallized from: ethanol, IR (KBr) (ν, cm
-1
):3280 (NH), 1683, 
1628(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 12.57 (s, 1H, NH), 9.10 (br, 1H, NH), 8.48 - 8.45 (d, 1H, ArH), 8.16 (s, 1H, 
ArH), 7.93- 7.87 (m, 3H, ArH), 7.64 - 7.59 (m, 3H, ArH), 3.38 – 3.34 (q, 2H, CH2), 1.17 – 1.13 (t, 3H, CH3). MS, m/z (%): 
394 (M 
+
, 20), 376(39), 245 (32), 105 (100). Anal.Calcd.For C16H15N2O2I (394.21): C, 48.75, H, 3.83; N, 7.11. Found: C, 
49.01, H, 3.88; N, 6.98. 
3.3.4  N–Methyl– 2 –benzamido –5– iodobenzamide (3d) 
Colour: white, M.P.: 188 – 190 C̊, Yield: 70%, Recrystallized from: ethanol, IR (KBr) (ν, cm
-1
): 3317 (NH), 1680, 
1627(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 12.63 (s, 1H, NH), 9.01 (br, 1H, NH), 8.49 – 8.47 (d, 1H, ArH), 8.16 (s, 1H, 
ArH), 7.94 - 7.88 (m, 3H, ArH), 7.64 - 7.57 (m, 3H, ArH), 2.82 – 2.80 (d, 3H, CH3). MS, m/z (%): 379(M 
+
- 1) (2), 348 (4), 
247 (2), 110 (1.5), 80 (100), 64 (50). Anal.Cacld.For C15H13N2O2I (380.18): C, 47.39, H, 3.44; N, 7.37. Found: C, 47.42, H, 
3.50; N, 7.42. 
3.3.5    N–Sec. Butyl –2–benzamido– 5– iodobenzamide (3e) 
Colour: white, M.P.: 146 – 148 C̊, Yield: 70%, Recrystallized from: ethanol, IR (KBr) (ν, cm
-1
): 3310 (NH), 1681, 
1625(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 12.48 (s, 1H, NH), 8.80 (d, 1H, NH), 8.46 - 8.43 (d, 1H, ArH), 8.16 (S, 1H, 
ArH), 7.93 - 7.87 (m, 3H, ArH), 7.64 - 7.59 (m, 3H, ArH), 4.10 – 3.95 (m, 1H, CH), 1.57 – 1.53 (m, 2H, CH2),1.16 – 1.14 (d, 
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3H, CH3), 0.90 – 0.85 (t, 3H, CH3). MS, m/z (%): 422(M 
+
, 6.5), 350 (15), 268 (12), 148 (33), 105 (100), 77 (43). 
Anal.Calcd.For C18H19N2O2I (422.26): C, 51.20, H, 4.53; N, 6.63. Found: C, 51.30, H, 4.53; N, 6.66. 
3.3.6   2–Benzamido–5–iodobenzoylhydrazide (3f) 
Colour: white, M.P.: 204 – 206 C̊, Yield: 70%,Recrystallized from ethanol, IR (KBr) (ν, cm
-1
): 3300, 3250 (NH), 1688, 
1640(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 12.45 (br, 1H, NH), 8.48 – 8.46 (d, 1H, ArH), 8.10 (s, 1H, ArH), 7.95 – 7.88 
(m, 3H, ArH), 7.78 - 7.40 (m, 3H, ArH), 5.67 (s, 1H, NH), 4.77 (br, 2H, NH2). MS, m/z (%): 381(M 
+
, 23), 287 (38), 237 (26), 
173 (23), 127 (31), 77 (52), 55 (100). Anal.Calcd.For C14H12N3O2I (381.17): C, 44.11, H, 3.17; N, 11.02. Found: C, 44.18, 
H, 2.99; N, 10.98. 
3.3.7.   N–Phenyl – 2– benzamido –5 – iodo–benzoylhydrazide (3g) 
Colour: white, M.P.: 250 –252 C̊, Yield: 60%, Recrystallized from toluene, IR (KBr) (ν, cm
-1
): 3325, 3188 (NH), 1664, 
1646(C=O). 
1
H– NMR (DMSO – d6): δ (ppm): 12.03 (s, 1H, NH), 10.75 – 10.74 (d, 1H, NH), 8.44 – 8.41( d, 1H, NH), 
8.31(s, 1H, ArH), 7.99 – 7.87 (m, 4H, ArH), 7.62 - 7.52 (m, 3H, ArH), 7.16 – 7.13 (m, 2H, ArH), 6.85 – 6.72 (m, 3H, ArH). 
MS, m/z (%): 457(M 
+
, 1), 439 (4), 348 (46), 245 (40), 105 (50), 80 (95), 64 (100). Anal.Calcd. For C20H16N3O2I (457.26): 
C, 52.53, H, 3.52; N, 9.19. Found: C, 52.60, H, 3.51; N, 9.21. 
3.4   General method for synthesis (4a – c):- 
A mixture of (2) (0.01 mol) and secondary amines, namely morpholine, piperidine and /or piperazine  (0.01 mol) in 1,4–
dioxane (30 mL) was refluxed for 5hr. The solid separated after concentration of 1,4–dioxane was filtered off, and 
recrystallized from a suitable solvent to give (4a – c). 
3.4.1    N–(4–Iodo–2(morpholine –1–carbonyl) phenylbenzamide (4a)  
Colour: colorless, M.P.: 204 - 206 C̊, Yield: 55%, Recrystallized from toluene/ethanol, IR (KBr) (ν, cm
-1
): 3196,3100 
(NH),1656(C=O).
1
H–NMR (DMSO – d6): δ (ppm): 10.25 (s, 1H, NH), 7.92 – 7.90 (d, 1H, ArH), 7.83 - 7.40 (m, 7H, ArH), 
3.58 – 3.55 (m, 8H, (CH2)4). MS, m/z (%): 434(M 
+
 -2, 13), 408 (19), 350 (25), 272 (16), 213 (14), 105 (92), 77 (100). 
Anal.Calcd. For C18H17N2O3I (436.24): C, 49.56, H, 3.92; N, 6.42. Found: C, 49.60, H, 3.95; N, 6.45. 
3.4.2    N–(4–Iodo–2(piperidine–1– carbonyl) phenylbenzamide (4b)  
Colour: white, M.P.: 149 - 151 ̊C, Yield: 50%, Recrystallized from ethanol, IR (KBr) (ν, cm
-1
): 3287 (NH), 1672(C=O). 
1
H– 
NMR (DMSO – d6): δ (ppm): 10.14 (br, 1H, NH), 7.88 (S, 1H, ArH), 7.87 (s, 1H, ArH), 7.79 (d, 1H, ArH), 7.64 (d, 1H, ArH), 
7.60 – 7.50 (m, 3H, ArH), 7.43 (d, 1H, ArH), 3.63 – 3.47 (m, 4H, N(CH2)2), 1.52 – 1.47 (m, 6H, (CH2)3). MS, m/z (%): 
434(M 
+
, 13), 372 (16), 270(15), 105(92), 77 (100). Anal.Calcd. For C19H19N2O2I (434.27): C, 52.54, H, 4.41; N, 6.45. 
Found: C, 52.58, H, 4.40; N, 6.50. 
3.4.3    N–(4–Iodo– 2 (piperazine –1–carbonyl) phenylbenzamide (4c)  
Colour: white, M.P.: 126 - 128 C̊, Yield: 65%, Recrystallized from toluene, IR (KBr) (ν, cm
-1
): 3250 (NH), 1671(C=O). 
1
H – 
NMR (DMSO – d6): δ (ppm): 11.75(s,1H, NH) ,8.03(d,2H,ArH),7.70-7.52(m,6H,ArH),5.10(s,1H,NH),2.67(s,8H,(CH2)4).MS, 
m/z (%): 434(M 
+
-1, 29), 360 (28), 268 (41), 177(30), 105 (100), 77(71). Anal.Calcd. For C18H18N3O2I (435.26): C, 49.67, 
H, 4.17; N, 9.65. Found: C, 49.88, H, 4.22; N, 9.80. 
3.5  General method for synthesis (5a – b):- 
A mixture of (2) (0.01 mol), ethyl alcohol and / or n – butyl alcohol (50 mL) in pyridine (1 mL) was refluxed for 4hr. The 
solid formed after concentration of the solvent was collected and recrystallized from a suitable solvent to give (5a) & (5b) 
respectively. 
3.5.1  Ethyl– 5–iodo– 2–benzamidobenzoate (5a) 
Colorless crystals, M.P.: 282 - 284°C, Yield: 70%, Recrystallized from benzene/ toluene, IR (KBr) (ν, cm
-1
): 3247 (NH), 
1690, 1669 (C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 11.48 (s, 1H, NH), 8.35 (d, 1H, ArH), 8.32 (d, 1H, ArH), 8.25- 8.01 
(m, 3H, ArH), 7.99 – 7.59 (m, 3H, ArH), 4.36 – 4.33 (q, 2H, CH2), 1.34 – 1.29 (t, 3H, CH3). MS, m/z (%): 395(M 
+
, 22), 
105(100), 77(50), 51 (18). Anal.Calcd. For C16H14NO3I (395.19): C, 48.63, H, 3.57; N, 3.54. Found: C, 48.88, H, 3.60; N, 
3.59. 
3.5.2   n-Butyl –5–iodo –2–benzamidobenzoate (5b) 
Colorless crystals, M.P.: 280 - 282°C, Yield: 77%, Recrystallized from ethanol, IR (KBr) (ν, cm
-1
): 3243 (NH), 1687, 1668 
(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 11.47 (s, 1H, NH), 8.35 – 8.32 (d, 1H, ArH), 8.23 (s, 1H, ArH), 8.01- 7.93 (m, 3H, 
ArH), 7.68 – 7.56 (m, 3H, ArH), 4.32 – 4.28 (t, 2H, CH2), 1.73 – 1.64 (m, 2H, CH2), 1.45 – 1.32 (m, 2H, CH2), 0.92 – 0.88 
(t, 3H, CH3). MS, m/z (%): 423(M 
+
, 12), 149(5), 105 (100), 77(25), 56 (70). Anal.Calcd. For C18H18NO3I (423.24): C, 51.08, 
H, 4.29; N, 3.31. Found: C, 51.22, H, 4.33; N, 3.38. 
3.6   General method for synthesis (6a–b):- 
A mixture of (2) (0.01 mol), hydrazine hydrate and/or hydroxylamine hydrochloride (0.01mol) in n–butanol (50 mL) was 
refluxed for 5hr. The solid formed after concentration of solvent was collected by filtration and recrystallized from a suitable 
solvent to give (6a)&(6b) respectively. 
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3.6.1   3–Amino– 6 –iodo– 2–phenylquinazolin– 4–one (6a) 
Colour: white, M.P.: 146 - 148°C, Yield: 75%, Recrystallized from toluene/ethanol. IR (KBr) (ν, cm
-1
): 3310 (NH), 1665 
(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 8.46 – 8.45 (d, 1H, ArH), 8.13 – 8.12 (d, 1H, ArH), 7.82 – 7.79 (m, 2H, ArH), 7.52 
– 7.44 (m, 4H, ArH), 5.67 (s, 2H, NH2). MS, m/z (%): 363 (M 
+
, 2), 349 (9), 285 (2), 105 (100), 77 (49). Anal.Calcd. for 
C14H10N3OI (363.15): C, 46.30, H, 2.77; N, 11.57. Found: C, 46.48, H, 2.80; N, 11.62. 
3.6.2  3–Hydroxy– 6 –iodo–2–phenylquinazolin–4–one (6b) 
Colour: white, M.P.: 210 - 212°C, Yield: 55%, Recrystallized from ethanol. IR (KBr) (ν, cm
-1
): 3432 (OH), 1661 (C=O). 
1
H – 
NMR (DMSO – d6): δ (ppm): 11.75 (s, 1H, OH), 8.52 – 8.50 (d, 1H, ArH), 8.30 (s, 1H, ArH), 7.96 – 7.83(m, 3H, ArH), 7.61 
– 7.52 (m, 3H, ArH). MS, m/z (%): 364 (M 
+
, 85), 334 (37), 245 (24), 178 (17), 105 (71), 77 (100). Anal.Calcd. for 
C14H9N2O2I (364.14): C, 46.18, H, 2.49; N, 7.69. Found: C, 46.23, H, 2.52; N, 7.70. 
3.7    6–Iodo–2–phenylquinazolin– 4–one (7) 
A mixture of (2) (0.01 mol) and ammonium acetate (0.04 mol) was heated in neat for 3hr at 170°C. After cooling, the 
reaction mixture was triturated with hot water,filteredoff, dried and recrystallized from ethanol to give (7). 
Colour: white, M.P.: 216 - 218°C, Yield: 45%. IR (KBr) (ν, cm
-1
): 3384, 3206 (NH), 1665 (C=O). 
1
H – NMR (DMSO – d6): δ 
(ppm): 8.39 (d, 1H, ArH), 8.24 (d, 1H, ArH), 8.23 (d, 1H, ArH), 8.19 – 8.17 (m, 2H, ArH, NH), 7.68 – 7.58 (m, 3H, ArH), 7.5 
(d, 1H, ArH).Anal.Calcd. for C14H9N2OI (348.14): C, 48.30, H, 2.60; N, 8.05. Found: C, 48.38, H, 2.57; N, 7.99. 
3.8    General method for synthesis (8a – b):- 
A mixture of (2) (0.01 mol), semicarbazide hydrochloride and /or thiosemicarbazide (0.01mol) in pyridine (30 mL) was 
refluxed for 5hr. After cooling, the reaction mixture was poured onto ice cold hydrochloric acid, the precipitate formed was 
collected, dried and recrystallized from a suitable solvent to give (8a)&(8b) respectively. 
3.8.1    4–Iodo–N–(2 – (5–oxo–4, 5–dihydro–1H –1, 2, 4 –triazol –3–yl) phenyl benzamide (8a) 
Colour: white, M.P.: 295 - 297°C, Yield: 55%, Recrystallized from methanol. IR (KBr) (ν, cm
-1
): 3321, 3278 (NH), 1667 
(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 10.54(s, 1H, NH), 8.45 (d, 1H, ArH), 8.16 – 8.12 (m, 2H, ArH), 7.97 – 7.45 (m, 
5H, ArH), 5.68 (s, 2H, 2 NH). MS, m/z (%): 406 (M 
+
, 26), 388 (43), 260 (40), 221 (44), 137 (42), 105 (67), 75 (100). 
Anal.Calcd . For C15H11N4O2I (406.18): C, 44.35, H, 2.73; N, 13.79. Found: C, 44.40, H, 2.75; N, 13.82. 
3.8.2     4–Iodo–N–(2–(5–thioxo–4, 5–dihydro –1H–1, 2, 4–triazol–3–yl) phenyl benzamide (8b) 
Colour: green, M.P.: 209 - 212°C, Yield: 65%, Recrystallized from methanol /ethanol. IR (KBr) (ν, cm
-1
): 3111 (NH), 1653 
(C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 11.70 (s, 1H, NH), 8.53 (d, 1H, ArH), 8.30 (d, 1H, ArH), 7.99 – 7.92 (m, 3H, ArH), 
7.66 – 7.56 (m, 3H, ArH), 5.70 (s, 2H, 2 NH). MS, m/z (%): 422 (M 
+
, 60), 380 (28), 341 (47), 280 (29), 179 (53), 80 (95), 
64 (100). Anal.Calcd. For C15H11N4OSI (422.24): C, 42.67, H, 2.62,N, 13.27;S,7.59. Found: C, 42.71, H, 2.66, N, 13.29; S, 
7.62. 
3.9    General method for synthesis (9) & (10):- 
A mixture of (2) (0.01mol) and sodium azide (0.01mol), in acetic acid (50 mL) was refluxed for 5hr. After cooling, the 
reaction mixture was poured onto water; the precipitate formed was collected, dried and fractionally recrystallized from 
benzene to give (9), while the insoluble part was crystallized from ethanol to give (10). 
3.9.1   5–Iodo–2–(5–phenyl– tetrazol–1-yl) benzoic acid (9)  
Colour: white, M.P.: 169 - 170°C, Yield: 40%. IR (KBr) (ν, cm
-1
): 3414(OH), 1697 (C=O). 
1
H – NMR (DMSO – d6): δ (ppm): 
12.15 (s, 1H, OH), 8.53 (d, 1H, ArH), 8.30 (d, 1H, ArH), 7.96 – 7.93 (m, 3H, ArH), 7.74 – 7.55 (m, 3H, ArH). MS, m/z (%): 
392 (M 
+
, 23), 349 (85), 284 (27), 233 (30), 162 (27), 77 (100).Anal. Calcd. For C14H9N4O2I (392.15): C, 42.88, H, 2.31; N, 
14.29. Found: C, 42.95, H, 2.55; N,14.33. 
3.9.2   1–Benzoyl –5–iodo –1, 3–dihydro–benzoimidazol– 2– one (10)  
Colour: white, M.P.: 245 - 247°C, Yield: 35%. IR (KBr) (ν, cm
-1
): 3337, 3115(NH), 1729, 1662 (C=O). 
1
H – NMR (DMSO – 
d6): δ (ppm): 11.40 (s, 1H, NH), 8.50 (d, 1H, ArH), 8.29 (d, 1H, ArH), 7.96 – 7.92 (m, 3H, ArH), 7.74 – 7.54 (m, 3H, ArH). 
MS, m/z (%): 364 (M 
+
, 24), 331 (22), 274 (29), 194(9), 142 (28), 77 (100).Anal. Calcd. for C14H9N2O2I (364.14): C, 46.18, 
H, 2.49; N, 7.69. Found: C, 46.23, H, 2.52;N,7.72. 
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